These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 8864420)
1. Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation. Katschinski M; Schirra J; Begliner C; Langbein S; Wank U; D'Amato M; Arnold R Eur J Clin Invest; 1996 Jul; 26(7):574-83. PubMed ID: 8864420 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade. Katschinski M; Steinicke C; Reinshagen M; Dahmen G; Beglinger C; Arnold R; Adler G Eur J Clin Invest; 1995 Feb; 25(2):113-22. PubMed ID: 7737260 [TBL] [Abstract][Full Text] [Related]
3. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans. Schirra J; Houck P; Wank U; Arnold R; Göke B; Katschinski M Gut; 2000 May; 46(5):622-31. PubMed ID: 10764704 [TBL] [Abstract][Full Text] [Related]
4. Antro-pyloric contractile patterns and transpyloric flow after meal ingestion in humans. Pallotta N; Cicala M; Frandina C; Corazziari E Am J Gastroenterol; 1998 Dec; 93(12):2513-22. PubMed ID: 9860417 [TBL] [Abstract][Full Text] [Related]
5. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Gabryelewicz A; Kulesza E; Konturek SJ Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088 [TBL] [Abstract][Full Text] [Related]
6. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808 [TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290 [TBL] [Abstract][Full Text] [Related]
8. GLP-1 regulates gastroduodenal motility involving cholinergic pathways. Schirra J; Nicolaus M; Woerle HJ; Struckmeier C; Katschinski M; Göke B Neurogastroenterol Motil; 2009 Jun; 21(6):609-18, e21-2. PubMed ID: 19220754 [TBL] [Abstract][Full Text] [Related]
9. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids. Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479 [TBL] [Abstract][Full Text] [Related]
10. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying. Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030 [TBL] [Abstract][Full Text] [Related]
11. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640 [TBL] [Abstract][Full Text] [Related]
12. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. McLaughlin J; Grazia Lucà M; Jones MN; D'Amato M; Dockray GJ; Thompson DG Gastroenterology; 1999 Jan; 116(1):46-53. PubMed ID: 9869601 [TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Konturek JW; Konturek SJ; Domschke W Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540 [TBL] [Abstract][Full Text] [Related]
14. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Schwizer W; Borovicka J; Kunz P; Fraser R; Kreiss C; D'Amato M; Crelier G; Boesiger P; Fried M Gut; 1997 Oct; 41(4):500-4. PubMed ID: 9391249 [TBL] [Abstract][Full Text] [Related]
15. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712 [TBL] [Abstract][Full Text] [Related]
16. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs. Niederau C; Karaus M Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649 [TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Niederau C; Faber S; Karaus M Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of cholecystokinin octapeptide on rat antrum, pylorus, and duodenum. Scheurer U; Varga L; Drack E; Bürki HR; Halter F Am J Physiol; 1983 Mar; 244(3):G266-72. PubMed ID: 6299117 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs. Teyssen S; Niebergall-Roth E; Rausch A; Beglinger C; Riepl RL; Chari S; Singer MV Pancreas; 1996 Nov; 13(4):407-16. PubMed ID: 8899802 [TBL] [Abstract][Full Text] [Related]
20. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Katschinski M; Dahmen G; Reinshagen M; Beglinger C; Koop H; Nustede R; Adler G Gastroenterology; 1992 Aug; 103(2):383-91. PubMed ID: 1634057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]